理解市场 | 康宁杰瑞制药-B 涨超 7% 此前宣布拟进行场内股份购回 市场关注 ESMO 大会重磅数据
ALPHAMAB-B rose over 7%, as of the time of writing, it increased by 6.79%, trading at HKD 14.63, with a transaction volume of HKD 37.113 million. In terms of news, ALPHAMAB announced that on October 16, the company spent HKD 5.483 million to repurchase 400,000 shares. The company previously announced that, based on the general authorization granted to the board (share repurchase authorization approved by shareholders at the annual general meeting on June 12, 2025), the board resolved on October 12, 2025, to repurchase the company's ordinary shares from the open market from time to time, with a maximum repurchase amount of HKD 20 million. In addition, the 2025 European Society for Medical Oncology (ESMO) will be held in Berlin, Germany, from October 17 to 21, and the latest research abstracts will be announced on the day of the presentation. It is reported that 23 studies from China have been selected for LBA, including key studies such as ALPHAMAB's KN026
According to the Zhitong Finance APP, ALPHAMAB-B (09966) rose over 7%, and as of the time of writing, it was up 6.79%, priced at HKD 14.63, with a transaction volume of HKD 37.113 million.
In terms of news, ALPHAMAB-B announced that on October 16, the company spent HKD 5.483 million to repurchase 400,000 shares. The company previously announced that, based on the general authorization granted to the directors (share repurchase authorization, approved by shareholders at the annual general meeting on June 12, 2025), the board of directors resolved on October 12, 2025, to periodically repurchase the company's ordinary shares from the open market, with a maximum repurchase amount of HKD 20 million.
Additionally, the 2025 European Society for Medical Oncology (ESMO) will be held from October 17 to 21 in Berlin, Germany, with the latest research abstracts to be announced on the day of the presentations. It is reported that 23 studies from China have been selected for LBA, including key studies such as ALPHAMAB's KN026
